Teleflex reported a 3.1% decrease in third quarter revenue to $628.3 million compared to the prior year. GAAP EPS decreased by 49.3% to $2.46, while adjusted diluted EPS decreased by 6.7% to $2.77. The company noted a negative impact of approximately $78 million due to COVID-19.
Third quarter revenues were $628.3 million, a 3.1% decrease year-over-year, or 4.1% on a constant currency basis.
GAAP diluted EPS from continuing operations was $2.46, compared to $4.85 in the prior year period.
Adjusted diluted EPS from continuing operations was $2.77, a 6.7% decrease year-over-year.
The company estimates COVID-19 had a net negative impact to revenue of approximately $78 million, or 12%.
Teleflex anticipates continued sequential improvement during the fourth quarter of 2020 compared to the third quarter results. The acquisition of Z-Medica is expected to be accretive to adjusted earnings per share in 2021.
Visualization of income flow from segment revenue to net income